Cyprus vs Iceland: Cause of death, by non-communicable diseases, ages 0-4, male
Cyprus
40.2%
in 2021
Iceland
40.1%
in 2021
Cyprus rank
45th
Iceland rank
46th
Cause of death, by non-communicable diseases, ages 0-4, male over time
- Cyprus
- Iceland
How they compare
Cyprus currently reports 40.2% against 40.1% in Iceland, a difference of 0.1%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Iceland ahead.
Cyprus ranks 45th and Iceland ranks 46th of 185 countries.
Across the 3 decades both report, Cyprus averaged higher in 1 and Iceland in 2.
Head to head by decade
| Decade | Cyprus | Iceland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 42.7% | 50.7% | 7.9% | Iceland |
| 2010s | 36.4% | 50.8% | 14.4% | Iceland |
| 2020s | 40.6% | 40.3% | 0.3% | Cyprus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, male, Cyprus or Iceland?
- Cyprus, at 40.2% against 40.1% in Iceland as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, male between Cyprus and Iceland?
- 0.1%, with Cyprus ahead.
- How many years of comparable data are there for Cyprus and Iceland?
- 6 years are reported by both, from 2000 to 2021.
- How do Cyprus and Iceland rank globally for cause of death, by non-communicable diseases, ages 0-4, male?
- Cyprus ranks 45th and Iceland ranks 46th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, male (% of total male deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 0-4 due to non-communicable diseases divided by number of all male deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.